The study of the pathogenesis of autoimmune disease, in which specific antibodies may be either the cause for or the consequence of disease, can be greatly improved by reducing the diversity of antibodies under investigation. This can be achieved very effectively in a transgenic mouse model. I addition, for a model of human disease, it is desirable to have a mouse with inducible heavy x light (HxL) chain genes chosen with specificity for a self antigen, e.g. to DNA, which allows for the analysis of various antibody characteristics (e.g, concentration, charge, affinity, class) at different stages of development. To create such a mouse for this specific purpose, we will generate a mouse transgenic for a transactivator and for immunoglobulin transgenes under a mouse transgenic for a transactivator and for immunoglobulin transgenes under a tetracycline-responsive promoter. In the presence of tetracycline in the drinking water (in concentrations much less than that present in the serum of mice and drink such water), the mice will not express any transgenic antibodies. However, after withdrawal from tetracycline, expression of transgenic antibodies will be induced. In this system, induction can be controlled over a range of five orders of magnitude. Our studies will focus on the development of the inducible monoclonal mouse model for use in lupus research; but this model also should be a useful example for the development of mice harboring any chosen specificity as models for other autoimmune diseases where a specific antibody response is suspected to be a cause.

Project Start
Project End
Budget Start
Budget End
Support Year
18
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Briggs, F B S; Ramsay, P P; Madden, E et al. (2010) Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis. Genes Immun 11:199-208
Yazdany, Jinoos; Yelin, Edward (2010) Health-related quality of life and employment among persons with systemic lupus erythematosus. Rheum Dis Clin North Am 36:15-32, vii
Janssens, A Cecile J W; Steyerberg, Ewout W; Jiang, Yebin et al. (2006) Value of the HLA-DRB1 shared epitope for predicting radiographic damage in rheumatoid arthritis depends on the individual patient risk profile. J Rheumatol 33:2383-9
Katz, Patricia P (2006) Childbearing decisions and family size among women with rheumatoid arthritis. Arthritis Rheum 55:217-23
Yelin, Edward H; Trupin, Laura S; Katz, Patricia P (2005) Impact of managed care on the use of biologic agents for rheumatoid arthritis. Arthritis Rheum 53:423-30
Katz, Patricia P (2005) Use of self-management behaviors to cope with rheumatoid arthritis stressors. Arthritis Rheum 53:939-49
von Scheven, E; Elder, M E (2005) Association between beta2-glycoprotein I gene polymorphisms and pediatric SLE and antiphospholipid antibodies. Lupus 14:440-4
Yang, Nan; Li, Hongzhe; Criswell, Lindsey A et al. (2005) Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine. Hum Genet 118:382-92
Chang, Wenhan; Shoback, Dolores (2004) Extracellular Ca2+-sensing receptors--an overview. Cell Calcium 35:183-96
Gorman, Jennifer D; Lum, Raymond F; Chen, John J et al. (2004) Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 50:400-12

Showing the most recent 10 out of 111 publications